Search

everythinglearnresearchcommunity

for

Search:↓

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

New therapy helps treat hair loss.

Men with self-diagnosed PFS-related ED have normal erectile hemodynamics.

N-Cadherin is crucial in scar formation, offering potential for scar prevention therapies.

Facial feminization surgery is effective in helping transgender women appear more feminine and has high patient satisfaction.

A new combination of tadalafil and finasteride improves drug performance and stability.

FAI is a better marker for predicting female hair loss than testosterone or SHBG alone.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

The authors suggest that 5-α-reductase inhibitors, like dutasteride, are effective in treating frontal fibrosing alopecia and should be the first-line treatment, with other options for severe cases. They also recommend further research on Janus kinase inhibitors.

A reliable method was developed to measure Finasteride and Tadalafil together, showing they degrade under certain conditions.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

A male patient developed frontal fibrosing alopecia after antiandrogen therapy for prostate cancer.

Frontal fibrosing alopecia can cause sudden hair loss on limbs, similar to scalp hair loss.

Prosopis farcta has strong antioxidants, useful for food and medicine.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

Trichoscopy helps diagnose and assess the severity of Frontal Fibrosing Alopecia.

Mollusc egg extract helps skin and hair cells grow and heal.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Most genetic mutations causing hypohidrotic ectodermal dysplasia in Russian patients are found in the EDA gene.

Early detection and stopping the drug are key to managing DRESS, and careful monitoring is important due to possible severe reactions.

Consider necrolytic acral erythema in similar cases and treat with oral zinc sulfate.

New method measures finasteride in plasma, finds two formulations bioequivalent.

European patent law now allows patents for new uses and dosages of known drugs, but protection scope is unclear.

The cream effectively and safely reduces facial hair in women.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

Some family members had a condition with both loose hair and unique eye changes, possibly indicating a new type of ectodermal dysplasia.

SPET-085 effectively inhibits an enzyme linked to prostate issues, similar to finasteride.